Advertisement
Correction

Correction: Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge

  • The PLOS ONE Staff
  • Published: February 28, 2014
  • DOI: 10.1371/journal.pone.0091631

The last sentence of the “WNV DNA Vaccine, Control Plasmid and E-protein” section of the Materials and Methods should read: “For protein booster vaccine formulation the E-protein was adjuvanted with 10 μg Matrix-M1 adjuvant (Novavax AB, Uppsala, Sweden).”

In addition, the following sentence should be inserted as the last sentence of the “Vaccination Procedures” section of the Materials and Methods: “Mice were boosted four weeks later either via an IM injection of the same does of WNV-DermaVir nanoparticles or via subcutaneous (s.c.) injection of recombinant E-protein ([28]) formulated with Matrix-M1 (a kind gift from Novavax AB, Uppsala, Sweden).”

Reference

  1. 1. De Filette M, Soehle S, Ulbert S, Richner J, Diamond MS, et al. (2014) Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge. PLoS ONE 9(2): e87837 doi:10.1371/journal.pone.0087837.